We use cookies to deliver our online services. Details of the cookies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you agree to our use of cookies. To close this message click close.

Hogan Lovells’ Litigation and Arbitration Practice Named “Washington Litigation Department of the Year” Finalist by National Law Journal

25 June 2013

WASHINGTON, D.C. 25 JUNE 2013 – Hogan Lovells is pleased to announce its selection as a Litigation Department of the Year finalist in The National Law Journal’s Washington Litigation Departments of the Year competition. The special report ranks Washington, D.C.-based litigation practices on each team’s notable wins, operations, headcounts, and revenues.

“We are honored to be named a Litigation Department of the Year finalist,” said Stephen Immelt, Co-Head of Hogan Lovells’ Litigation and Arbitration practice. “Being recognized as a leading litigation shop speaks to our strong presence in Washington, D.C., as well as the ability of our Washington, D.C. team to provide outstanding service to clients nationally and internationally.”

In awarding Hogan Lovells this honor, The National Law Journal touted our “regular presence in the U.S. Supreme Court” and noted that our litigators are “scoring big wins in everything from complex regulatory matters to a pro bono death penalty case.” The publication also called attention to our “all-star litigation lineup,” referencing partners Robert Bennett and Neal Katyal.

Our marquee healthcare litigation team, including groups dedicated to class action defense and fraud matters, was also spotlighted by The National Law Journal. It specifically recognized a significant victory by partners Craig Hoover, E. Desmond Hogan, and Miranda Berge in a nationwide class action brought against a healthcare client, as well as the team’s role defending numerous Blue Cross and Blue Shield companies in over 35 antitrust class actions filed across the country.

Hogan Lovells’ Washington, D.C. team was also commended for settling a high-profile Foreign Corrupt Practices Act investigation into medical device manufacturer Orthofix International N.V., helping the company secure a favorable deal with enforcers.

Loading data